Baumdick ME, Niehrs A, Degenhardt F, Schwerk M, Hinrichs O, Jordan-Paiz A, Padoan B, Wegner LHM, Schloer S, (..), Altfeld M, Bunders MJ. (2023). HLA-DP on Epithelial Cells enables Tissue Damage by NKp44+ NK Cells in Ulcerative Colitis. Gastroenterology. 2023 Jul 14:S0016-5085(23)04772-8.

Beisel C, Jordan-Paiz A, Köllmann S, Ahrenstorf AE, Padoan B, Barkhausen T, Addo MM, Altfeld M. (2023). Sex differences in the percentage of IRF5 positive B cells are associated with higher production of TNF-α in women in response to TLR9 in humans. Biol Sex Differ. 2023 Feb 22;14(1):11.

Kroll MK, Schloer S, Candan P, Korthals N, Wenzel C, Ihle H, Gilhaus K, Liedtke KR, Schöfbänker M, Surmann B, Schröter R, Neugebauer U, Mall G, Oswald S, Ludwig S, Rescher U, Vollenbröker B, Ciarimboli G. (2023). Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells. Biomolecules. 2023 Mar 3;13(3):472.

Lücke J, Heinrich F, Malsy J, (..), Bunders MJ, Altfeld M, Sauter G, Giannou AD, Krasemann S, Ondruschka B, Huber S (2023). Intestinal IL-1β Plays a Role in Protecting against SARS-CoV-2 Infection The Journal of Immunology ji2200844.

Möller KJ, Wegner L, Malsy J, Baumdick ME, Borggrewe M, Jordan-Paiz A, (..), Altfeld M, Bernink JH, Perez D, Reinshagen K, Bunders MJ. (2023). Expanded ILC2s in human infant intestines promote tissue-growth. Mucosal Immunol. 2023 Apr 28:S1933-0219(23)00030-2.

Ufer F, Ziegler SM, Altfeld M, Friese MA. (2023). Case report: JAK inhibition as promising treatment option of fatal RVCLS due to TREX1 mutation (pVAL235Glyfs*6). Front Neurol. 2023 Feb 21;14:1118369.

Zhang Z, Duri K, Duisters KLW, Schoeman JC, Chandiwana P, Lindenburg P, Jaeger J, Ziegler S, Altfeld M, Kohler I, Harms A, Gumbo FZ, Hankemeier T, Bunders MJ. (2023). Altered methionine-sulfone levels are associated with impaired growth in HEU-children. AIDS. 2023 Apr 12.

Ziegler AE, Fittje P, Müller LM, Ahrenstorf AE, Hagemann K, ..., Schramm C, Martrus G, Bunders MJ, Altfeld M, Lunemann S. (2023). The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56bright NK cells. Front Immunol. 2023 Feb 9;14:1117320.

Braun SA, Bauer AT, Németh C, Rózsa A, Rusch L, Erpenbeck L, Schloer S, Silling S, Metze D, Gerber PA, Schneider SW, Gyulai R, Homey B. (2022). Immunothrombotic Mechanisms Induced by Ingenol Mebutate Lead to Rapid Necrosis and Clearance of Anogenital Warts. Int J Mol Sci. 2022 Nov 2;23(21):13377.

Cords L, Woost R, Kummer S, Brehm TT, Kluge S, Schmiedel S, Jordan S, Lohse AW, Altfeld M, Addo MM, Schulze zur Wiesch J, Beisel C (2022). Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infection Cytokine 162 156109

Faist A, Schloer S, Mecate-Zambrano A, Janowski J, Schreiber A, Boergeling Y, Conrad BCG, Kumar S, Toebben L, Schughart K, Baumgardt M, Kessler M, Hoenzke K, Hocke A, Trautmann M, Hartmann W, Kato H, Rescher U, Christersson A, Kuehn J, Mellmann A, Wolff T (2022). Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier. Antiviral Res. 2022 Nov 21;209:105475.

Fittje P, Hœlzemer A, Garcia-Beltran WF, Vollmers S, Niehrs A, Hagemann K, Martrus G, Körner C, Kirchhoff F, Sauter D, Altfeld M (2022). HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells. PLoS Pathog. 2022 Jun 24;18(6):e1010572.

Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, Berrios C, Ofoman O, Chang CC, Hauser BM, Feldman J, Roederer AL, Gregory DJ, Poznansky MC, Schmidt AG, Iafrate AJ, Naranbhai V, Balazs AB (2022). mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. Cell. 2022 Jan 6:S0092-8674(21)01496-3.

Hagemann K, Riecken K, Jung J, Hildebrandt H, Menzel S, Bunders M, Fehse B, Koch-Nolte F, Heinrich F, Peine S, Schulze Zur Wiesch J, Brehm TT, Addo MM, Lütgehetmann M, Altfeld M (2022). Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients. Eur J Immunol. 2022 Aug;52(8):1297-1307.

Höfle J, Trenkner T, Kleist N, Schwane V, Vollmers S, Barcelona B, Niehrs A, Fittje P, Huynh-Tran VH, Sauter J, Schmidt AH, Peine S, Hoelzemer A, Richert L, Altfeld M, Körner C (2022). Engagement of TRAIL triggers degranulation and IFNγ production in human natural killer cells. EMBO Rep. 2022 Jun 27:e54133.

Mensching L, Hoelzemer A (2022). NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune Responses. Front Immunol. 2022 May 27;13:883728.

Müller AL, Casar C, Preti M, Krzikalla D, Gottwick C, Averhoff P, Rosenstiel P, Gelderblom M, Altfeld M, Lohse AW, Steinmann S, Sebode M, Krause J, Schwinge D, Schramm C, Carambia A, Herkel J (2022). Inflammatory type 2 conventional dendritic cells contribute to murine and human cholangitis. J Hepatol. 2022 Jul 4:S0168-8278(22)02923-3.

Nette F, Guerra de Souza AC, Laskay T, Ohms M, Dömer D, Drömann D, Rapoport DH (2022). Method for simultaneous tracking of thousands of unlabeled cells within a transparent 3D matrix. PLoS One. 2022 Jun 24;17(6):e0270456.

Nickel L, Sünderhauf A, Rawish E, Stölting I, Derer S, Thorns C, Matschl U, Othman A, Sina C, Raasch W (2022). The AT1 Receptor Blocker Telmisartan Reduces Intestinal Mucus Thickness in Obese Mice. Front Pharmacol. 2022 Mar 31;13:815353.

Sampson O, Lim N, White J, Vieira V, Kløverpris H, Adland E, Conlon C, Skelly D, Jones L, Stafford L, Jamsen A, Barnes E, Dunachie S, Frater J, Klenerman P, Altfeld M, Goulder P (2022). A simple, robust flow cytometry-based whole blood assay for investigating sex differential interferon alpha production by plasmacytoid dendritic cells. J Immunol Methods. 2022 Mar 24:113263.

Schlemeyer T, Ohnezeit D, Virdi S, Körner C, Weißelberg S, Starzonek S, Schumacher U, Grundhoff A, Indenbirken D, Albertini S, Fischer N (2022). Merkel cell carcinoma and immune evasion: Merkel cell polyomavirus small T-antigen induced surface changes can be reverted by therapeutic intervention. J Invest Dermatol. 2022 May 27:S0022-202X(22)00404-3.

Schloer S, Goretzko J, Rescher U (2022). Repurposing Antifungals for Host-Directed Antiviral Therapy? Pharmaceuticals (Basel). 2022 Feb 10;15(2):212.

Schloer S, Treuherz D, Faist A, Witt M, Wunderlich K, Wiewrodt R, Wiebe K, Barth P, Wälzlein JH, Kummer S, Balkema-Buschmann A, Ludwig S, Brunotte L, Rescher U (2022). 3D ex vivo tissue platforms to investigate the early phases of influenza A virus- and SARS-CoV-2-induced respiratory diseases. Emerg Microbes Infect. 2022 Aug 24:1-30.

Schreiber A, Ambrosy B, Planz O, Schloer S, Rescher U, Ludwig S (2022). The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs. Pharmaceutics. 2022 Aug 25;14(9):1776.

Vollmers S, Lobermeyer A, Niehrs A, Fittje P, Indenbirken D, Nakel J, Virdi S, Brias S, Trenkner T, Sauer G, Peine S, Behrens GMN, Lehmann C, Meurer A, Pauli R, Postel N, Roider J, Scholten S, (...), Hoelzemer A, Altfeld M, Körner C (2022). Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C. Front Immunol. 2022 Jul 15;13:922252.